Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
Vale SA
VALE
KB Home
KBH
Apple
AAPL
US Stock MarketDetailed Quotes
STRO Sutro Biopharma
- 1.790
- +0.050+2.87%
Close Feb 14 16:00 ET
- 1.790
- +0.000+0.01%
Post 20:01 ET
147.60MMarket Cap-1.15P/E (TTM)
1.860High1.750Low647.77KVolume1.760Open1.740Pre Close1.17MTurnover0.87%Turnover RatioLossP/E (Static)82.46MShares6.13052wk High1.33P/B133.36MFloat Cap1.51052wk Low--Dividend TTM74.50MShs Float28.300Historical High--Div YieldTTM6.32%Amplitude1.510Historical Low1.798Avg Price1Lot Size
About Sutro Biopharma Company
Sutro Biopharma, Inc. engages in the drug discovery, development and manufacture of pharmaceutical products. It focuses on the next generation cancer and autoimmune therapeutics. The company was founded by James R. Swartz and Sutanto Widjaja on April 21, 2003 and is headquartered in South San Francisco, CA.
Company Profile
SymbolSTRO
Company NameSutro Biopharma
Listing DateSep 27, 2018
Issue Price15.00
Founded2003
CEOMr. William J. Newell
MarketNASDAQ
Employees324
Fiscal Year Ends12-31
Address111 Oyster Point Boulevard
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-881-6500
Websitehttp://www.sutrobio.com
Company Executives
- Name
- Position
- Salary
- William J. Newell
- Chief Executive Officer and Director
- 2.13M
- Linda A. Fitzpatrick
- Chief People and Communications Officer
- --
- Dr. Anne Borgman, M.D.
- Chief Medical Officer
- 2.34M
- Hans-Peter Gerber
- Chief Scientific Officer
- --
- Edward C. Albini
- Chief Financial Officer and Chief Accounting Officer
- --
- Jane Chung
- President and Chief Operating Officer
- --
- Venkatesh Srinivasan
- Chief Technical Operations Officer
- --
- Connie L. Matsui
- Chairman of the Board
- 173.11K
- Sukhi Jagpal
- Director
- --
- Joseph M. Lobacki
- Independent Director
- 152.11K
- James P. Panek
- Independent Director
- 138.11K
- Daniel H. Petree
- Independent Director
- 140.11K
- Dr. Michael Dybbs, PhD
- Independent Director
- 133.11K
- Dr. Jon Marc Wigginton, M.D.
- Independent Director
- 145.11K
- Heidi Hunter
- Independent Director
- 150.28K
- Dr. John G. Freund,M.D.
- Independent Director
- 138.11K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.